Advertisement
Collaboration › Details
Uniqure–HC Wainwright: investor conference, 201904 supply service Uniqure attends HC Wainwright Global Life Sciences Conference in London
Period | 2019-04-09 | |
Region | London, Greater London | |
Country | United Kingdom (GB) | |
Partner, 1st | Uniqure N.V. (Nasdaq: QURE) | |
Product | H.C. Wainwright Global Life Sciences Conference 2019 London | |
Product 2 | gene therapy | |
Uniqure N.V.. (3/29/19). "Press Release: Uniqure to Participate in Multiple Upcoming Industry Conferences". Lexington, MA & Amsterdam.
uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it will participate in the following upcoming conferences in April:
> Stifel First Annual CNS Day in Boston, Mass.
Matt Kapusta, chief executive officer at uniQure, will participate in a panel discussion, “Gene Therapy Strategies in CNS,” on Monday, April 1 at 10:00 a.m. ET.
> Guggenheim Rare Disease & Gene Therapy Day in Boston, Mass.
Matt Kapusta will attend and participate in one-on-one investor meetings throughout the day on Tuesday, April 2.
> H.C. Wainwright Global Life Sciences Conference in London, England
Sander van Deventer, M.D., Ph.D., chief scientific officer at uniQure, will attend and participate in one-on-one investor meetings on Tuesday, April 9.
> EASL International Liver Congress in Vienna, Austria
Valerie Sier-Ferreira, Ph.D., principal scientist of immunology research at uniQure, will present “Lipid nanoparticle pre-treatment improves adeno-associated virus diffusion in the primate liver and enables an increase of therapeutic transgene expression” on Thursday, April 11 at 10:00 a.m. CET.
Anna Majowicz, Ph.D., scientist at uniQure, will present “Adeno-associated virus-serotype-specific transduction patterns in mice and non-human primates liver tissue: Implications for therapeutic efficacy” on April 11 at the 10:00 a.m. CET poster session.
> Kempen Life Science Conference in Amsterdam, the Netherlands
Sander van Deventer will attend and participate in investor one-on-one meetings on Tuesday, April 16.
> Alliance for Regenerative Medicine (ARM) Meeting on the Med in Barcelona, Spain
Jonathan Garen, chief business officer at uniQure, will present a corporate update on Tuesday, April 23 at 11:15 a.m. CET.
> American Society of Gene and Cell Therapy (ASGCT) 21st Annual Meeting in Washington, D.C.
uniQure will deliver multiple data presentations at the meeting, which takes place Monday, April 29 through Thursday, May 2. Specific details to follow when the meeting abstracts are released.
About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and other severe genetic diseases. www.uniQure.com
uniQure Contacts
For Investors:
Maria E. Cantor Eva M. Mulder
Direct: 339-970-7536 Direct: +31 20 240 6103
For Media:
Tom Malone
Direct: 339-970-7558
Record changed: 2019-04-16 |
Advertisement
More documents for Uniqure (Group)
- [1] Uniqure N.V.. (5/15/23). "Press Release: Uniqure Announces Sale of Royalty Interest in Hemgenix for up to $400 Million". Lexington, MA & Amsterdam....
- [2] Uniqure N.V.. (12/21/20). "Press Release: uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program". Lexington, MA & Amsterdam....
- [3] Uniqure N.V.. (3/29/19). "Press Release: Uniqure to Participate in Multiple Upcoming Industry Conferences". Lexington, MA & Amsterdam....
- [4] Synpromics Ltd.. (12/5/18). "Press Release: Uniqure Incorporates Novel Synthetic Promoter Developed by Synpromics in New Preclinical Target". Edinburgh....
- [5] Uniqure N.V.. (8/30/18). "Press Release: Uniqure to Participate at Multiple Upcoming Conferences". Lexington, MA & Amsterdam....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top